FDA Inspection 1235608 — Tianjin Jinjin Pharmaceutical Co. Ltd.
The FDA completed an inspection of Tianjin Jinjin Pharmaceutical Co. Ltd. on Mar 29, 2024 in Xiqing Economic. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 29, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xiqing Economic (China)